Showing results (11-20 of 235) with videos related to

Sort By:
Pageof 24
Annual Review of Pharmacology and Toxicology|November 13, 2012
Direct-acting antiviral agents for hepatitis C virus infectionJennifer J Kiser, Charles Flexner
Bioengineering & Translational Medicine|August 2, 2018
Harnessing nanostructured systems for improved treatment and prevention of HIV diseaseMaya Monroe, Charles Flexner, Honggang Cui
Current Opinion in HIV and AIDS|November 6, 2018
Creating demand for long-acting formulations for the treatment and prevention of HIV, tuberculosis, and viral hepatitisCharles Flexner, David L Thomas, Susan Swindells
International Journal of Antimicrobial Agents|November 9, 2020
Long-acting drugs and formulations for the treatment and prevention of HIV infectionCharles Flexner, Andrew Owen, Marco Siccardi, et al.
The Lancet. Oncology|May 17, 2011
Use of antineoplastic agents in patients with cancer who have HIV/AIDSMichelle A Rudek, Charles Flexner, Richard F Ambinder
Annals of the Academy of Medicine, Singapore|January 11, 2013
Unexpected drug-drug interactions in human immunodeficiency virus (HIV) therapy: induction of UGT1A1 and bile efflux transporters by EfavirenzLawrence S U Lee, Paul Pham, Charles Flexner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2022
The LEAP Process: Streamlining the Development of Long-Acting Products and Formulations for Infectious DiseasesCharles Flexner, Marco Siccardi, Fazila Bunglawala, et al.
Current Opinion in HIV and AIDS|October 9, 2013
Treatment optimization: an outline for future successCharles Flexner, Ben Plumley, David H Brown Ripin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2006
Interactions between natural health products and antiretroviral drugs: pharmacokinetic and pharmacodynamic effectsLawrence S Lee, Adriana S A Andrade, Charles Flexner
Pageof 24